Raise by Fusion42
Fusion42 Scout Wire
Capital Reports
Who's InvestingWeekly · Mon 08:00 UTCCapital UnlockedBi-weekly · Wed 08:00 UTC
Benchmarks
Benchmarks HomeFundsRoundsSectors
AI VC IndexCapital FlowAbout

Switch product

Fusion42RaiseScoutWire

Capital Reports

All editionsWho's InvestingWeekly · Mon 08:00 UTCCapital UnlockedBi-weekly · Wed 08:00 UTC

Database & benchmarks

Benchmarks HomeFundsRoundsSectorsStagesAI VC IndexCapital Flow Index

Account

Sign in
← Back

Drug Discovery: venture funds and startups

Sector hub · Health

52 funds17 startups$29.9B AUM

◆ Funds tracked

52

◆ Combined AUM

$29.9B

◆ Startups tracked

17

◆ Raised between them

$227.2M

◆ Overview

Fusion42 tracks 52 venture funds in Drug Discovery with $29.9B in combined assets under management, and 17 startups that have raised $227.2M between them. The data below is live from the same database that powers Raise and Scout, and is continuously enriched as new rounds and funds are announced.

Part of the Raise fund database and the Scout startup database by Fusion42 — the same live data Arthur reasons over.

◆ Highlights

Active funds in Drug Discovery include Forbion Growth Opportunities Fund IV and Forbion Ventures Fund VIII, LumaBio Fund I, Mitsui Link-Fund, offshore RMB venture fund and Fresenius Ventures; startups in Drug Discovery include Estuary Biotherapeutics, SereNeuro Therapeutics, ZoeNCure Therapeutics, Cascader Ltd and Kasvu Therapeutics. Each name links through to a full machine-readable profile — its backers, rounds and related Wire analysis — and the tables below list every entity Fusion42 tracks in Drug Discovery, refreshed as new rounds and funds are announced.

◆ Funds in Drug Discovery (52 tracked)

FundTypeHQ
Forbion Growth Opportunities Fund IV and Forbion Ventures Fund VIIIvcNetherlands
LumaBio Fund IvcUnited States
Mitsui Link-Fundcorporate vcJapan
offshore RMB venture fundvcHong Kong
Fresenius Venturescorporate vcGermany
Fresenius Venturescorporate vcGermany
Dimension IIIvcUnited States
AlleyCorp Fund IIvcUnited States
Criteria Bio VenturesvcSpain
Yosemite Fund IIvcUnited States
Bertelsmann Healthcare Investmentscorporate vcGermany
Genesys University Seed FundvcCanada
Elanco Venturescorporate vcUnited States
Kos Biotechnology FundvcGreece
Star51 CapitalvcUnited States
Third Rock Ventures VIIvcUnited States
Lotte Healthcare and Biopharmaceutical CVCcorporate vcJapan
BOLDcorporate vcFrance
Asabys Innvierte Tech TransfervcSpain
YosemitevcUnited States
Montana Children's HealthvcSpain
Cancer Breakthrough FundvcCanada
Servier Venturescorporate vcFrance
WorldQuant GenesisvcIsrael
AI Health FundvcUnited States
Show all 50 funds
Northern GritstonevcUnited Kingdom
Spain–Boston Biotechnology initiativevcSpain
Life Sciences Venture FundvcCanada
Immune Boost CapitalvcUnited States
Medicxi VvcUnited Kingdom
Sofinnova Capital XIvcFrance
ASA FundvcJapan
ArchvcUnited States
UTokyo IPC Fund 2vcJapan
Lupus VenturesvcUnited States
Boehringer Ingelheim Venture Fundcorporate vcGermany
PxB FundvcUnited States
T1D FundvcUnited States
Crossroads Health VenturesvcUnited States
Epidarex Capital IVvcUnited Kingdom
LifeArc Venturescorporate vcUnited Kingdom
Blue FundvcFrance
InceptionBiovcSpain
Breakout VenturesvcUnited States
Braidwell Partners FundvcUnited States
New Jersey Innovation Evergreen FundvcUnited States
DimensionvcUnited States
Celiac Disease Foundation Impact FundvcUnited States
UBC Catalyst Venture FundvcCanada
Santé Ventures Fund 5vcUnited States

◆ Startups in Drug Discovery (17 tracked)

StartupStageHQRaised
Estuary Biotherapeuticsseries-aUnited States$93M
SereNeuro Therapeuticspre-seedUnited States—
ZoeNCure TherapeuticsseedIndia$2.1M
Cascader LtdseedUnited Kingdom—
Kasvu Therapeuticsseries-aFinland$34.4M
Altis Labsseries-aCanada$25M
Biolevateseries-aFrance$34.4M
Halmos LabsseedSweden$0.5M
sci2scipre-seedGermany$1.4M
Omega Ophthalmics, LLCseries-aUnited States$7M
Lyora Therapeuticspre-seedUnited States$2.5M
Waypoint Bioseries-aUnited States$20M
SwishXseedIndia$2.2M
ALP BioseedSwitzerland$2.1M
Healome TherapeuticsseedUnited Kingdom$2.7M
Thalia Therapeutics—United Kingdom—
Telum Therapeutics—Spain—

◆ Recent Wire analysis